Health Care & Life Sciences » Pharmaceuticals | Shenzhen Neptunus Bioengineering Co. Ltd.

Shenzhen Neptunus Bioengineering Co. Ltd. A | Mutual Funds

Mutual Funds that own Shenzhen Neptunus Bioengineering Co. Ltd. A

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
27,000,072
1.45%
7,000,072
2.92%
12/31/2017
14,067,387
0.76%
-20,038,141
6.3%
12/31/2017
6,743,698
0.36%
6,743,698
3.67%
12/31/2017
Nanfang CSI 500 ETF
6,714,775
0.36%
-460,400
0.19%
12/31/2017
6,000,000
0.32%
500,000
3.35%
12/31/2017
4,289,500
0.23%
4,289,500
1.65%
12/31/2017
4,252,895
0.23%
4,252,895
0.53%
12/31/2017
Lion Balanced Fund
2,800,000
0.15%
2,800,000
0.71%
12/31/2017
2,370,575
0.13%
-517,600
0.64%
12/31/2017
2,036,956
0.11%
-15,781,875
1.69%
12/31/2017

About Shenzhen Neptunus Bioengineering Co.

View Profile
Address
24/F, Haiwang Yinhe Technology Bldg
Shenzhen Guangdong 518057
China
Employees -
Website http://www.neptunus.com
Updated 07/08/2019
Shenzhen Neptunus Bioengineering Co., Ltd. engages in the research and development, production and distribution of pharmaceutical products. Its products include chemical pharmaceuticals, biological pharmaceuticals, antibiotics, narcotic drugs, biochemical drugs and other traditional Chinese medicines and herbs. The company was founded in 1989 and is headquartered in Shenzhen, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.